BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37823356)

  • 1. Plasma pharmacokinetics of clorsulon following administration of a single subcutaneous or intravenous injection to cattle.
    Rehbein S; Kvaternick V; Kellermann M; Hamel D; Antretter A; Johnson C
    J Vet Pharmacol Ther; 2024 Mar; 47(2):87-94. PubMed ID: 37823356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of ivermectin and clorsulon treatment on productivity of a cow-calf herd on the southern Oregon coast.
    Rickard LG; Zimmerman GL; Hoberg EP; Bishop JK; Pettitt RJ
    Vet Parasitol; 1992 Feb; 41(1-2):45-55. PubMed ID: 1561761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of clorsulon used concurrently with ivermectin for control of Fasciola hepatica in Florida beef cattle.
    Courtney CH; Shearer JK; Plue RE
    Am J Vet Res; 1985 Jun; 46(6):1245-6. PubMed ID: 3839640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ceftiofur sodium in Peekapoo dogs following a single intravenous and subcutaneous injection.
    Yang F; Yang F; Wang H; Zhang CS; Song ZW; Shao HT; Zhang M
    J Vet Pharmacol Ther; 2020 Jul; 43(4):325-330. PubMed ID: 32281146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of parenteral administration of doramectin or a combination of ivermectin and clorsulon on control of gastrointestinal nematode and liver fluke infections and on growth performance in cattle.
    Loyacano AF; Skogerboe TL; Williams JC; DeRosa AA; Gurie JA; Shostrom VK
    J Am Vet Med Assoc; 2001 May; 218(9):1465-8. PubMed ID: 11345312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clorsulon pharmacokinetics in sheep and goats following oral and intravenous administration.
    Sundlof SF; Whitlock TW
    J Vet Pharmacol Ther; 1992 Sep; 15(3):282-91. PubMed ID: 1433492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in sheep.
    Abu-Basha EA; Bani Ismail Z; Abu Alhaijaa H; Hamzeh E; Idkaidek NM
    J Vet Pharmacol Ther; 2021 Jan; 44(1):79-85. PubMed ID: 32748450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of doramectin and ivermectin in cattle.
    Toutain PL; Upson DW; Terhune TN; McKenzie ME
    Vet Parasitol; 1997 Sep; 72(1):3-8. PubMed ID: 9403971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma pharmacokinetics and milk residues of flunixin and 5-hydroxy flunixin following different routes of administration in dairy cattle.
    Kissell LW; Smith GW; Leavens TL; Baynes RE; Wu H; Riviere JE
    J Dairy Sci; 2012 Dec; 95(12):7151-7. PubMed ID: 23040013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of gamithromycin in cattle with comparison of plasma and lung tissue concentrations and plasma antibacterial activity.
    Huang RA; Letendre LT; Banav N; Fischer J; Somerville B
    J Vet Pharmacol Ther; 2010 Jun; 33(3):227-37. PubMed ID: 20557439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of gamithromycin after intravenous and subcutaneous administration in pigs.
    Wyns H; Meyer E; Plessers E; Watteyn A; De Baere S; De Backer P; Croubels S
    Res Vet Sci; 2014 Feb; 96(1):160-3. PubMed ID: 24331716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs.
    Gokbulut C; Karademir U; Boyacioglu M; McKellar QA
    Vet Parasitol; 2006 Feb; 135(3-4):347-54. PubMed ID: 16280198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of a novel formulation of ivermectin after administration to goats.
    González A; Sahagun AM; Diez MJ; Fernandez N; Sierra M; Garcia JJ
    Am J Vet Res; 2006 Feb; 67(2):323-8. PubMed ID: 16454640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministration of ivermectin and abamectin affects milk pharmacokinetics of the antiparasitic clorsulon in Assaf sheep.
    Blanco-Paniagua E; Álvarez-Fernández L; Millán-García A; Rivas G; Álvarez AI; Merino G
    Front Vet Sci; 2023; 10():1268658. PubMed ID: 37929285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ivermectin in the yak (Bos grunniens).
    Dupuy J; Yin H; Luo JX; Yang DY; Guan GQ; Ma ML; Sutra JF; Lespine A; Boulard C; Alvinerie M
    Vet Parasitol; 2003 Nov; 117(1-2):153-7. PubMed ID: 14597289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of a commercial formulation of ivermectin after subcutaneous administration to sheep.
    Canga AG; Sahagun A; Diez MJ; Fernandez N; Sierra M; Garcia JJ
    Am J Vet Res; 2007 Jan; 68(1):101-6. PubMed ID: 17199426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle.
    Hutchinson GW; Dawson K; Fitzgibbon CC; Martin PJ
    Vet Parasitol; 2009 Jun; 162(3-4):278-84. PubMed ID: 19375232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of eprinomectin in cats when administered in a novel topical combination of fipronil, (S)-methoprene, eprinomectin and praziquantel.
    Kvaternick V; Kellermann M; Knaus M; Rehbein S; Rosentel J
    Vet Parasitol; 2014 Apr; 202(1-2):2-9. PubMed ID: 24703069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle.
    Lifschitz A; Virkel G; Pis A; Imperiale F; Sanchez S; Alvarez L; Kujanek R; Lanusse C
    Vet Parasitol; 1999 Oct; 86(3):203-15. PubMed ID: 10511102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic, pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma.
    Moreau P; Karamanesht II; Domnikova N; Kyselyova MY; Vilchevska KV; Doronin VA; Schmidt A; Hulin C; Leleu X; Esseltine DL; Venkatakrishnan K; Skee D; Feng H; Girgis S; Cakana A; van de Velde H; Deraedt W; Facon T
    Clin Pharmacokinet; 2012 Dec; 51(12):823-9. PubMed ID: 23018466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.